Adipocyte size and liability to cell death

Obesity Surgery

Volumn 16, Issue 6, 2006, Pages 804-806

  Monteiro, Rosário ^a,b   De Castro, Paulo M S T ^b   Calhau, Conceição ^a   Azevedo, Isabel ^a,c  

^a University of Porto   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c Institute of Pharmacology and Therapeutics   (Portugal)

Author keywords

Adipocyte size; Inflammation; Macrophages; Metabolic syndrome; Morbid obesity; Obesity

Indexed keywords

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; CELL DEATH; CELL SIZE; HUMAN; HYPERTROPHY; INFLAMMATION; MACROPHAGE; OBESITY; PRIORITY JOURNAL; RISK REDUCTION;

ADIPOCYTES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DEATH; CELL SIZE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; HUMANS; INFLAMMATION; RUPTURE; STRESS, MECHANICAL; VINCRISTINE;

EID: 33745019170     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089206777346600     Document Type: Article

References (23)

1. Clement K, Viguerie N, Poitou C et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004; 18: 1657-69.
2. Trayhurn P, Woods IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-55.
3. Weisberg S, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-808.
4. Wellen K, Hotamisligil G. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112: 1785-8.
5. Xu H, Barnes G, Yang Q et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-30.
6. Cottam DR, Mattar SG, Barinas-Mitchell E et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 2004; 14: 589-600.
7. William IL, Chowienczyk PJ, Wheatcraft SB et al. Endothelial function and weight loss in obese humans. Obes Surg 2005; 15: 1055-60.
8. Cinti S, Mitchell G, Barbatelli G et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lip Res 2005; 46: 2347-55.
9. Zienkiewicz OC, Taylor RL, Zhu JZ. The Finite Element Method: Its Basis and Fundamentals, 6th Edn. Oxford: Butterworth-Heinemann 2005.
10. ABAQUS Analysis User's Manual, version 6.4
11. Tresca H. Compt Rend Savants Étrangers, Paris (1865, 1868, 1870).
12. Carey V J, Walters EE, Colditz GA et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol 1997; 145: 614-9.
13. Lean MEJ, Man TS, Seidell JC. Impairment of health and quality of life in people with large waist circumference. Lancet 1998; 351: 853-6.
14. Cobb WS, Burns JM, Kercher KW et al. Normal intraabdominal pressure in healthy adults. J Surg Res 2005; 129: 231-5.
15. Malbrain MLNG, Chiumello D, Pelosi P et al. Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med 2004; 30: 822-9.
16. Lambert DM, Marceau S, Forse RA. Intra-abdominal pressure in the morbidly obese. Obes Surg 2005; 15: 1225-32.
17. Murphy KG, Bloom SR. Are all fats created equal? Nat Med 2006; 12: 32-3.
18. Fukuhara A, Matsuda M, Nishizawa M et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426-30.
19. Berndt J, Kloting N, Kralisch S et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005; 54: 2911-6.
20. Hug C, Lodish HF. Visfatin: a new adipokine. Science 2005; 307: 366-7.
21. Furukawa S, Fujita T, Shimabukuro M et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-61.
22. Melissas J, Malliaraki N, Papadakis JA et al. Plasma antioxidant capacity in morbidly obese patients before and after weight loss. Obes Surg 2006; 16: 314-20.
23. Lambeth JD. Nox enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004; 4: 181-9.